Mangiferin, an anti-HIV-1 agent targeting protease and effective against resistant strains

Molecules

Volumn 16, Issue 5, 2011, Pages 4264-4277

  Wang, Rui Rui ^a   Gao, Yue Dong ^a,b   Ma, Chun Hui ^c   Zhang, Xing Jie ^a,b   Huang, Cheng Gang ^c   Huang, Jing Fei ^a   Zheng, Yong Tang ^a  

^a KUNMING INSTITUTE OF ZOOLOGY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Anti HIV agents; Drug resistance; HIV 1; Mangiferin; Protease

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE; MANGIFERIN; P16 PROTEASE, HUMAN IMMUNODEFICIENCY VIRUS 1; XANTHONE DERIVATIVE;

ANTIVIRAL RESISTANCE; ARTICLE; CELL LINE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECT; ENZYME ACTIVE SITE; ENZYMOLOGY; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; METABOLISM; MONONUCLEAR CELL; MUTATION; PROTEIN BINDING; VIROLOGY;

ANTI-HIV AGENTS; CATALYTIC DOMAIN; CELL LINE; DRUG RESISTANCE, VIRAL; HIV PROTEASE; HIV-1; HUMANS; LEUKOCYTES, MONONUCLEAR; MODELS, MOLECULAR; MUTATION; PROTEIN BINDING; XANTHONES;

EID: 79957620500     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules16054264     Document Type: Article

References (38)

1. Deeks, S.G.; Wrin, T.; Liegler, T.; Hoh, R.; Hayden, M.; Barbour, J.D.; Hellmann, N.S.; Petropoulos, C.J.; McCune, J.M.; Hellerstein, M.K.; Grant, R.M. Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia. N. Engl. J. Med. 2001, 344, 472-480. (Pubitemid 32164898)
2. Condra, J.H.; Schleif, W.A.; Blahy, O.M.; Gabryelski, L.J.; Graham, D.J.; Quintero, J.C.; Rhodes, A.; Robbins, H.L.; Roth, E.; Shivaprakash, M.; et al. In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors. Nature 1995, 374, 569-571.
3. Gulnik, S.V.; Suvorov, L.I.; Liu, B.; Yu, B.; Anderson, B.; Mitsuya, H.; Erickson, J.W. Kinetic characterization and cross-resistance patterns of HIV-1 protease mutants selected under drug pressure. Biochemistry 1995, 34, 9282-9287.
4. Tisdale, M.; Myers, R.E.; Maschera, B.; Parry, N.R.; Oliver, N.M.; Blair, E.D. Cross-resistance analysis of human immunodeficiency virus type 1 variants individually selected for resistance to five different protease inhibitors. Antimicrob. Agents Chemother. 1995, 39, 1704-1710.
5. Markowitz, M.; Mohri, H.; Mehandru, S.; Shet, A.; Berry, L.; Kalyanaraman, R.; Kim, A.; Chung, C.; Jean-Pierre, P.; Horowitz, A.; et al. Infection with multidrug resistant, dual-tropic HIV-1 and rapid progression to AIDS: a case report. Lancet 2005, 365, 1031-1038. (Pubitemid 40386780)
6. Clavel, F.; Hance, A.J. HIV drug resistance. N. Engl. J. Med. 2004, 350, 1023-1035. (Pubitemid 38269279)
7. Deeks, S.G. Treatment of antiretroviral-drug-resistant HIV-1 infection. Lancet 2003, 362, 2002-2011. (Pubitemid 37548427)
8. Little, S.J.; Holte, S.; Routy, J.P.; Daar, E.S.; Markowitz, M.; Collier, A.C.; Koup, R.A.; Mellors, J.W.; Connick, E.; Conway, B.; et al. Antiretroviral-drug resistance among patients recently infected with HIV. N. Engl. J. Med. 2002, 347, 385-394. (Pubitemid 34851830)
9. Yeni, P. Update on HAART in HIV. J. Hepatol. 2006, 44, S100-S103. (Pubitemid 43053883)
10. Boden, D.; Markowitz, M. Resistance to human immunodeficiency virus type 1 protease inhibitors. Antimicrob. Agents Chemother. 1998, 42, 2775-2783. (Pubitemid 28501203)
11. De Clercq, E. Looking back in 2009 at the dawning of antiviral therapy now 50 years ago an historical perspective. Adv. Virus Res. 2009, 73, 1-53.
12. Poppe, S.M.; Slade, D.E.; Chong, K.T.; Hinshaw, R.R.; Pagano, P.J.; Markowitz, M.; Ho, D.D.; Mo, H.; Gorman, R.R., III.; Dueweke, T.J.; et al. Antiviral activity of the dihydropyrone PNU- 140690, a new nonpeptidic human immunodeficiency virus protease inhibitor. Antimicrob. Agents Chemother. 1997, 41, 1058-1063. (Pubitemid 27194185)
13. Muzammil, S.; Armstrong, A.A.; Kang, L.W.; Jakalian, A.; Bonneau, P.R.; Schmelmer, V.; Amzel, L.M.; Freire, E. Unique thermodynamic response of tipranavir to human immunodeficiency virus type 1 protease drug resistance mutations. J. Virol. 2007, 81, 5144-5154. (Pubitemid 46744425)
14. Sanchez, G.M.; Re, L.; Giuliani, A.; Nunez-Selles, A.J.; Davison, G.P.; Leon-Fernandez, O.S. Protective effects of Mangifera indica L. extract, mangiferin and selected antioxidants against TPA-induced biomolecules oxidation and peritoneal macrophage activation in mice. Pharmacol. Res. 2000, 42, 565-573.
15. Muruganandan, S.; Gupta, S.; Kataria, M.; Lal, J.; Gupta, P.K. Mangiferin protects the streptozotocin-induced oxidative damage to cardiac and renal tissues in rats. Toxicology 2002, 176, 165-173. (Pubitemid 34692590)
16. Garrido, G.; Delgado, R.; Lemus, Y.; Rodriguez, J.; Garcia, D.; Nunez-Selles, A.J. Protection against septic shock and suppression of tumor necrosis factor alpha and nitric oxide production on macrophages and microglia by a standard aqueous extract of Mangifera indica L. (VIMANG). Role of mangiferin isolated from the extract. Pharmacol. Res. 2004, 50, 165-172. (Pubitemid 38737248)
17. Andreu, G.P.; Delgado, R.; Velho, J.A.; Curti, C.; Vercesi, A.E. Iron complexing activity of mangiferin, a naturally occurring glucosylxanthone, inhibits mitochondrial lipid peroxidation induced by Fe2+-citrate. Eur. J. Pharmacol. 2005, 513, 47-55. (Pubitemid 40692245)
18. Jagetia, G.C.; Baliga, M.S. Radioprotection by mangiferin in DBAxC57BL mice: A preliminary study. Phytomedicine 2005, 12, 209-215. (Pubitemid 40348622)
19. Guha, S.; Ghosal, S.; Chattopadhyay, U. Antitumor, immunomodulatory and anti-HIV effect of mangiferin, a naturally occurring glucosylxanthone. Chemotherapy 1996, 42, 443-451. (Pubitemid 26379933)
20. Zheng, M.S.; Lu, Z.Y. Antiviral effect of mangiferin and isomangiferin on herpes simplex virus. Chin. Med. J. (Engl.) 1990, 103, 160-165.
21. Zhu, X.M.; Song, J.X.; Huang, Z.Z.; Wu, Y.M.; Yu, M.J. Antiviral activity of mangiferin against herpes simplex virus type 2 in vitro. Zhongguo Yao Li Xue Bao 1993, 14, 452-454.
22. Yoosook, C.; Bunyapraphatsara, N.; Boonyakiat, Y.; Kantasuk, C. Anti-herpes simplex virus activities of crude water extracts of Thai medicinal plants. Phytomedicine 2000, 6, 411-419.
23. Makare, N.; Bodhankar, S.; Rangari, V. Immunomodulatory activity of alcoholic extract of Mangifera indica L. in mice. J. Ethnopharmacol. 2001, 78, 133-137. (Pubitemid 32994781)
24. Leiro, J.; Arranz, J.A.; Yanez, M.; Ubeira, F.M.; Sanmartin, M.L.; Orallo, F. Expression profiles of genes involved in the mouse nuclear factor-kappa B signal transduction pathway are modulated by mangiferin. Int. Immunopharmacol. 2004, 4, 763-778. (Pubitemid 38595533)
25. Wu, G.; Robertson, D.H.; Brooks, C.L., III.; Vieth, M. Detailed analysis of grid-based molecular docking: A case study of CDOCKER-A CHARMm-based MD docking algorithm. J. Comput. Chem. 2003, 24, 1549-1562.
26. Gund, P. Three-dimensional pharmacophoric pattern searching. Prog. Mol. Subcell Biol. 1977, 5, 117-143.
27. Shen, M.Y.; Sali, A. Statistical potential for assessment and prediction of protein structures. Protein Sci. 2006, 15, 2507-2524. (Pubitemid 44771688)
28. Miura, I.; Hostettman, K.; Nakanishi, K. 13-C-NMR of naturally occurring xanthone aglycones and glycosides. Nouv. J. Chim. 1978, 2, 653-657.
29. Wang, R.R.; Gu, Q.; Wang, Y.H.; Zhang, X.M.; Yang, L.M.; Zhou, J.; Chen, J.J.; Zheng, Y.T. Anti-HIV-1 activities of compounds isolated from the medicinal plant Rhus chinensis. J. Ethnopharmacol. 2008, 117, 249-256.
30. Wang, Q.; Wang, Y.T.; Pu, S.P.; Zheng, Y.T. Zinc coupling potentiates anti-HIV-1 activity of baicalin. Biochem. Biophys. Res. Commun. 2004, 324, 605-610. (Pubitemid 39345559)
31. Wang, R.R.; Yang, L.M.; Wang, Y.H.; Pang, W.; Tam, S.C.; Tien, P.; Zheng, Y.T. Sifuvirtide, a potent HIV fusion inhibitor peptide. Biochem. Biophys. Res. Commun. 2009, 382, 540-544.
32. Wang, Y.H.; Tang, J.G.; Wang, R.R.; Yang, L.M.; Dong, Z.J.; Du, L.; Shen, X.; Liu, J.K.; Zheng, Y.T. Flazinamide, a novel beta-carboline compound with anti-HIV actions. Biochem. Biophys. Res. Commun. 2007, 355, 1091-1095. (Pubitemid 46366939)
33. Wang, Y.H.; Wang, R.R.; Yang, L.M.; Li, J.F.; Xu, W.M.; Zheng, Y.T. Expression and Purification of HIV-1 Protease and the Establishment of a Method for Protease Inhibitor Screening. Virol. Sin. 2006, 21, 126-130.
34. Kirchmair, J.; Laggner, C.; Wolber, G.; Langer, T. Comparative analysis of protein-bound ligand conformations with respect to catalyst's conformational space subsampling algorithms. J. Chem. Inf. Model. 2005, 45, 422-430. (Pubitemid 40635351)
35. Smellie, A.; Teig, S.L.; Towbin, P. Poling: Promoting Conformational Variation. J. Comp. Chem. 1995, 16, 171-187.
36. Barnum, D.; Greene, J.; Smellie, A.; Sprague, P. Identification of common functional configurations among molecules. J. Chem. Inf. Comput. Sci. 1996, 36, 563-571. (Pubitemid 126539357)
37. Eswar, N.; Webb, B.; Marti-Renom, M.A.; Madhusudhan, M.S.; Eramian, D.; Shen, M.Y.; Pieper, U.; Sali, A. Comparative protein structure modeling using Modeller. Curr. Protoc. Bioinformatics 2006, Chapter 5, Unit 5-6.
38. Feyfant, E.; Sali, A.; Fiser, A. Modeling mutations in protein structures. Protein Sci. 2007, 16, 2030-2041. (Pubitemid 47367126)